Compare ProShares Ultra Bloomberg Natural Gas ETF (BOIL) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares Ultra Bloomberg Natural Gas ETF vs Cronos Group Inc — how do they compare? ProShares Ultra Bloomberg Natural Gas ETF trades at $20.8, while Cronos Group Inc trades at $3.08 (market cap $1.11B). The key difference: Cronos Group Inc is trading nearer its 52-week high, ProShares Ultra Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| BOIL | CRON | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $87.24 | $3.27 |
52-Week Low | $18.74 | $2.30 |
Market Cap | — | $1.11B |
Enterprise Value | — | $310.67M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BOIL trades at $19.12, up 2.03% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The stock faces resistance near $20 and support at $18. Recent news highlights natural gas market volatility and company-specific updates, including an investor webcast and annual meeting results. Financial ratios are unavailable, limiting fundamental assessment.
The outlook remains cautious due to bearish technicals and reliance on natural gas price swings. Risks include energy market fluctuations and competitive pressures. Analyst sentiment is mixed, with some viewing BOIL as a tactical tool amid volatility, but the lack of fundamental data warrants careful evaluation for long-term investment.
CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.
Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ProShares Ultra Bloomberg Natural Gas ETF
BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.
Read more on BOIL →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
